Jianyou Pharmaceutical (603707.SH) subsidiary receives US FDA registration approval for additional manufacturing site for amikacin sulfate injection

Zhitong Finance APP news, Jianyou Co., Ltd. (603707.SH) issued an announcement that its subsidiary Meitheal Pharmaceuticals Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for Amikacin Sulfate Injection (500mg/2mL (250mg/mL) and 1g/4mL (250mg/mL)) to add a manufacturing site, approving production at the site of Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.